We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$11.8B
AUM Growth
+$2.01B
Cap. Flow
+$1.18B
Cap. Flow %
9.96%
Top 10 Hldgs %
34.42%
Holding
1,405
New
267
Increased
199
Reduced
181
Closed
321

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$182M
2
GSK icon
GSK
GSK
+$88.3M
3
KVUE icon
Kenvue
KVUE
+$88.1M
4
FWONK icon
Liberty Media Series C
FWONK
+$48.4M
5
CTLT
CATALENT, INC.
CTLT
+$47.9M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$85.1M
2
PXD
Pioneer Natural Resource Co.
PXD
+$73.4M
3
APH icon
Amphenol
APH
+$58.5M
4
CRM icon
Salesforce
CRM
+$34.8M
5
GRMN
Garmin
GRMN
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 8.14%
2 Healthcare 5%
3 Consumer Discretionary 2.96%
4 Consumer Staples 2.69%
5 Communication Services 2.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
476
PUT
Lam Research
LRCX
$382B
$2.34M 0.02%
22,000
EA icon
477
CALL
Electronic Arts
EA
$52.4B
$2.34M 0.02%
16,800
-10,000
-37% -$1.32M
PRU icon
478
CALL
Prudential Financial
PRU
$41.7B
$2.33M 0.02%
19,900
BRKR icon
479
Bruker
BRKR
$9.2B
$2.33M 0.02%
36,456
+25,673
+238% +$1.93M
JCI icon
480
Johnson Controls International
JCI
$87.5B
$2.31M 0.02%
34,811
+1,448
+4% +$97.5K
GS icon
481
CALL
Goldman Sachs
GS
$313B
$2.31M 0.02%
5,100
-7,200
-59% -$3.16M
MELI icon
482
CALL
Mercado Libre
MELI
$91.3B
$2.3M 0.02%
1,400
ITCI
483
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.28M 0.02%
33,289
+12,329
+59% +$855K
GOOG icon
484
PUT
Alphabet (Google) Class C
GOOG
$3.9T
$2.27M 0.02%
12,400
OKE icon
485
CALL
Oneok
OKE
$58.7B
$2.27M 0.02%
27,800
BUD icon
486
PUT
AB InBev
BUD
$158B
$2.25M 0.02%
38,700
+15,900
+70% +$974K
AXP icon
487
CALL
American Express
AXP
$223B
$2.25M 0.02%
9,700
-9,300
-49% -$2.15M
SKGR
488
DELISTED
SK Growth Opportunities Corporation Class A Common Stock
SKGR
$2.22M 0.02%
200,000
PSX icon
489
PUT
Phillips 66
PSX
$82.9B
$2.22M 0.02%
15,700
BBIO icon
490
PUT
BridgeBio Pharma
BBIO
$16.5B
$2.21M 0.02%
87,100
+47,100
+118% +$1.29M
TJX icon
491
CALL
TJX Companies
TJX
$170B
$2.2M 0.02%
+20,000
New +$2.01M
ALNY icon
492
Alnylam Pharmaceuticals
ALNY
$36.3B
$2.18M 0.02%
8,971
-62,400
-87% -$9.85M
BSX icon
493
PUT
Boston Scientific
BSX
$65.8B
$2.18M 0.02%
28,300
BLCO icon
494
Bausch + Lomb
BLCO
$5.77B
$2.17M 0.02%
149,640
+104
+0.1% +$1.56K
PSX icon
495
CALL
Phillips 66
PSX
$82.9B
$2.16M 0.02%
15,300
ASML icon
496
PUT
ASML
ASML
$675B
$2.15M 0.02%
2,100
NUE icon
497
CALL
Nucor
NUE
$56.4B
$2.13M 0.02%
13,500
AKAM icon
498
CALL
Akamai
AKAM
$16.8B
$2.12M 0.02%
23,500
CMPOW
499
DELISTED
CompoSecure Inc Warrant
CMPOW
$2.11M 0.02%
4,734,659
ECHO
500
EchoStar
ECHO
$25.5B
$2.1M 0.02%
118,027

Similar funds

LMR Partners's Q2 2024 Portfolio in Review

As of Q2 2024, LMR Partners held 1,405 positions worth $11.8B, up 20% from $9.83B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

LMR Partners deployed $1.18B of net new capital in Q2 2024, opening 267 new positions and adding to 199 existing holdings. Its largest new stake was Kenvue: 4,549,655 shares worth $82.7M.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, down from 9.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $85.1M trimmed.

  • LMR Partners's largest Q2 2024 buy was Kenvue: 4,549,655 shares worth $82.7M.
  • LMR Partners added most to Invesco QQQ Trust in Q2 2024, an estimated $182M increase.
  • LMR Partners's biggest Q2 2024 reduction was Microsoft, cutting an estimated $85.1M.
  • LMR Partners fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $73.4M.
  • LMR Partners's ten largest holdings make up 34% of its $11.8B portfolio in Q2 2024.
  • LMR Partners opened 267 new positions and closed 321 in Q2 2024.
  • LMR Partners's portfolio value rose 20% quarter-over-quarter to $11.8B.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.